| Baseline (BA) sample | Clinical Interview (CI) sample | Re-assessment (RA) sample |
---|---|---|---|
Number of respondents | 418 | 99 | 230 |
Sex | Â | Â | Â |
   Males, no (%) | 163 (39, 0) | 42 (42, 4) | 55 (23, 9)* |
   Females, no (%) | 255 (61, 0) | 57 (57, 6) | 175 (76, 1) |
Age (mean, S.D.) | 16-87 (μ = 35, 3; S.D. = 15, 0) | 16-74 (μ = 34, 7; S.D. = 14, 1) | 16-77 (μ = 37, 2; S.D. = 13, 9)* |
Treatment condition 1 | Â | Â | Â |
   Direct, no (%) | 97 (54, 8) | 52 (52, 5)* | 90 (39, 1)* |
   Indirect, no (%) | 92 (23, 2) | 47 (47, 5) | 77 (33, 5) |
   Control, no (%) | 229 (22, 0) | - | 63 (27, 4) |